• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Pneumonia. >Burden of pneumococcal disease in adults aged 65?years and older: an Australian perspective
【24h】

Burden of pneumococcal disease in adults aged 65?years and older: an Australian perspective

机译：65岁及以上成年人肺炎球菌疾病的负担：澳大利亚的观点

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background The burden of pneumococcal disease in adults aged 65?years and older in Australia is not well defined. This retrospective cross-sectional study calculated rates for pneumococcal pneumonia using data from the Australian Institute of Health and Welfare and from the Bettering Evaluation and Care of Health program. Methods Invasive pneumococcal disease (IPD) incidence was calculated using National Notifiable Diseases Surveillance System data. Population estimates and pneumonia mortality data were from the Australian Bureau of Statistics. Medical costs were derived from Australian Refined Diagnosis Related Groups and the literature. Clinical and economic burden of pneumococcal pneumonia hospitalisations and general practitioner (GP) visits were described and compared with IPD. Results For adults aged ≥65?years, pneumococcal pneumonia hospitalisation incidence was 274 per 100,000 population in 2011–2012. From 2004 to 2012, a mean of 2235 pneumonia hospitalisation deaths were recorded, corresponding to a case fatality rate of 6.1?%. GP visits accounted for the largest portion of healthcare encounters, with an annual average of 455 pneumococcal pneumonia GP visits per 100,000 population from 2008 to 2013. In 2012, IPD incidence was 19 per 100,000 population. The estimated annual costs of treating pneumococcal pneumonia hospitalisations and GP visits were A$55,722,136 and A$1,604,189, respectively. Estimated costs for IPD were A$1,172,986. Conclusions The healthcare and economic burden of pneumococcal disease in adults aged ≥65?years in Australia is substantial, with the incidence of pneumococcal pneumonia hospitalisation nearly 15-fold higher than for IPD. Despite this, it remains less recognised than other infectious diseases such as influenza.
机译：背景在澳大利亚，年龄在65岁及以上的成年人中的肺炎球菌疾病负担尚不明确。这项回顾性横断面研究使用澳大利亚卫生与福利研究所和“改善健康状况的评估”计划的数据计算了肺炎球菌性肺炎的发生率。方法使用国家法定疾病监测系统数据计算侵袭性肺炎球菌疾病（IPD）的发生率。人口估计数和肺炎死亡率数据来自澳大利亚统计局。医疗费用来自澳大利亚精细诊断相关小组和文献。描述了肺炎球菌性肺炎住院和全科医生就诊的临床和经济负担，并与IPD进行了比较。结果2011年至2012年，年龄≥65岁的成年人的肺炎球菌肺炎住院率为274 / 100,000。从2004年到2012年，平均记录有2235例肺炎住院死亡，对应的病死率为6.1％。全科医生就诊在医疗保健中所占比例最大，从2008年至2013年，每年平均每100,000人口有455例肺炎球菌性肺炎全科医生就诊。2012年，IPD发病率为每10万人中19例。每年治疗肺炎球菌肺炎住院和全科医生就诊的估计费用分别为55,722,136澳元和1,604,189澳元。 IPD的估计成本为1,172,986澳元。结论在澳大利亚，≥65岁的成年人中肺炎球菌疾病的医疗保健和经济负担是巨大的，住院肺炎球菌性肺炎的发病率比IPD高近15倍。尽管如此，它仍然没有像其他传染病（例如流感）那样被认可。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号